An analysis of the impact of rotavirus vaccine in 25 countries found that the rates of vaccination in all countries were highest and risk mortality lowest in the top two wealth quintile’s coverage. Countries differed in the relative inequities in these two underlying variables. Cost per DALYs averted in substantially greater in the higher quintiles. In all countries, the greatest potential vaccine benefit was in the poorest quintiles; however, reduced vaccination coverage lowered the projected vaccine benefit.
Full Citation:
Rheingans, R., Atherly, D., and Anderson, J.. 2012. Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness. Vaccine. 30(1).
Title of Article: Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness
Author(s): Rheingans, R., Atherly, D., and Anderson, J.
Publication Year: 2012
Publication Name: Vaccine
Publication Volume: 30(1)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/22520124/
DOI (Digital Object Identifier): 10.1016/j.vaccine.2012.01.018
Topics: Health
Disease Vaccines: Rotavirus
Countries: Bangladesh | Burkina Faso | Cambodia | Cameroon | Chad | Congo - The Democratic Republic Of The | Ethiopia | Ghana | Guinea | Haiti | India | Kenya | Lesotho | Liberia | Malawi | Mali | Mozambique | Nepal | Niger | Nigeria | Senegal | Sierra Leone | Tanzania - United Republic Of | Uganda | Zambia
WHO Regions: Africa | Americas | South-East Asia